Myricetin suppresses UVB-induced skin cancer by targeting Fyn

Cancer Research

Volumn 68, Issue 14, 2008, Pages 6021-6029

  Sung, Keun Jung ^a   Ki, Won Lee ^b   Byun, Sanguine ^a   Nam, Joo Kang ^a,c   Sung, Hwan Lim ^a   Heo, Yong Seok ^b   Bode, Ann M ^c   Bowden, G Tim ^d   Hyong, Joo Lee ^a   Dong, Zigang ^c  

^a Seoul National University   (South Korea)

^b Konkuk University   (South Korea)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ADENOSINE TRIPHOSPHATE; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYRICETIN; PROTEIN KINASE FYN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; ANTINEOPLASTIC AGENT; FLAVONOID; FYN PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG TARGETING; ENZYME ACTIVITY; FEMALE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; SKIN CANCER; ULTRAVIOLET B RADIATION; ANIMAL; BIOLOGICAL MODEL; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PHOSPHORYLATION; RADIATION INJURY; SKIN TUMOR; ULTRAVIOLET RADIATION;

ANIMALS; ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLAVONOIDS; MICE; MICE, INBRED ICR; MODELS, BIOLOGICAL; NEOPLASMS, RADIATION-INDUCED; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FYN; SKIN NEOPLASMS; TRANSCRIPTION FACTOR AP-1; ULTRAVIOLET RAYS;

EID: 48649090159     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-0899     Document Type: Article

References (45)

1. Melnikova VO, Ananthaswamy HN. Cellular and molecular events leading to the development of skin cancer. Mutation research 2005;571:91-106.
2. Setlow RB. The wavelengths in sunlight effective in producing skin cancer: a theoretical analysis. Proc Natl Acad Sci U S A 1974;71:3363-6.
3. Ley RD. Photoreactivation in humans. Proc Natl Acad Sci U S A 1993;90:4337.
4. Matsumura Y, Ananthaswamy HN. Short-term and long-term cellular and molecular events following UV irradiation of skin: implications for molecular medicine. Exp Rev Mol Med 2002;4:1-22.
5. Matsumura Y, Ananthaswamy HN. Toxic effects of ultraviolet radiation on the skin. Toxicol Applied Pharmacol 2004;195:298-308.
6. Bode AM, Dong Z. Mitogen-activated protein kinase activation in UV-induced signal transduction. Sci STKE 2003;2003:RE2.
7. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Ann Rev Biochem 2000;69:145-82.
8. Chen W, Tang Q, Gonzales MS, Bowden GT. Role of p38 MAP kinases and ERK in mediating ultraviolet-B induced cyclooxygenase-2 gene expression in human keratinocytes. Oncogene 2001;20:3921-6.
9. Fischer SM, Lo HH, Gordon GB, et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog 1999;25:231-40.
10. Lee JL, Mukhtar H, Bickers DR, Kopelovich L, Athar M. Cyclooxygenases in the skin: pharmacological and toxicological implications. Toxicol Applied Pharmacol 2003;192:294-306.
11. Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Ann Rev Cell Dev Biol 1997;13:513-609.
12. Cartwright CA, Coad CA, Egbert BM. Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis. J Clin Investig 1994;93:509-15.
13. Matsumoto T, Jiang J, Kiguchi K, et al. Overexpression of a constitutively active form of c-src in skin epidermis increases sensitivity to tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Mol Carcinog 2002;33:146-55.
14. Muthuswamy SK, Muller WJ. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo. Oncogene 1995;11:1801-10.
15. Park J, Meisler AI, Cartwright CA. c-Yes tyrosine kinase activity in human colon carcinoma. Oncogene 1993;8:2627-35.
16. Calautti E, Missero C, Stein PL, Ezzell RM, Dotto GP. fyn tyrosine kinase is involved in keratinocyte differentiation control. Genes Dev 1995;9:2279-91.
17. Matsumoto T, Jiang J, Kiguchi K, et al. Targeted expression of c-Src in epidermal basal cells leads to enhanced skin tumor promotion, malignant progression, and metastasis. Cancer Res 2003;63:4819-28.
18. Resh MD. Fyn, a Src family tyrosine kinase. Int J Biochem Cell Biol 1998;30:1159-62.
19. Li X, Yang Y, Hu Y, et al. αvβ6-Fyn signaling promotes oral cancer progression. J Biol Chem 2003;278:41646-53.
20. Calautti E, Grossi M, Mammucari C, et al. Fyn tyrosine kinase is a downstream mediator of Rho/PRK2 function in keratinocyte cell-cell adhesion. J Cell Biol 2002;156:137-48.
21. +/- mice. Carcinogenesis 1997;18:1473-6.
22. Mariotti A, Kedeshian PA, Dans M, Curatola AM, Gagnoux-Palacios L, Giancotti FG. EGF-R signaling through Fyn kinase disrupts the function of integrin α6β4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion. J Cell Biol 2001;155:447-58.
23. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev 2003;3:768-80.
24. German JB, Walzem RL. The health benefits of wine. Ann Rev Nutr 2000;20:561-93.
25. Hakkinen SH, Karenlampi SO, Heinonen IM, Mykkanen HM, Torronen AR. Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries. J Agric Food Chem 1999;47:2274-9.
26. Sellappan S, Akoh CC. Flavonoids and antioxidant capacity of Georgia-grown Vidalia onions. J Agric Food Chem 2002;50:5338-42.
27. Ribeiro de Lima MT, Waffo-Teguo P, Teissedre PL, et al. Determination of stilbenes (trans-astringin, cis-and trans-piceid, and cis- and trans-resveratrol) in Portuguese wines. J Agric Food Chem 1999;47:2666-70.
28. Lee KW, Kang NJ, Rogozin EA, et al. Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1. Carcinogenesis 2007;28:1918-27.
29. Karin M. Mitogen-activated protein kinase cascades as regulators of stress responses. Ann N Y Acad Sci 1998;851:139-46.
30. Bode AM, Dong Z. Signal transduction pathways: targets for chemoprevention of skin cancer. Lancet Oncol 2000;1:181-8.
31. Ding M, Feng R, Wang SY, et al. Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity. J Biol Chem 2006;281:17359-68.
32. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995;80:179-85.
33. Mallikarjuna G, Dhanalakshmi S, Singh RP, Agarwal C, Agarwal R. Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling. Cancer Res 2004;64:6349-56.
34. Aziz MH, Reagan-Shaw S, Wu J, Longley BJ, Ahmad N. Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease? FASEB J 2005;19:1193-5.
35. Das M, Khan WA, Asokan P, Bickers DR, Mukhtar H. Inhibition of polycyclic aromatic hydrocarbon-DNA adduct formation in epidermis and lungs of SENCAR mice by naturally occurring plant phenols. Cancer Res 1987;47:767-73.
36. Mukhtar H, Das M, Khan WA, Wang ZY, Bik DP, Bickers DR. Exceptional activity of tannic acid among naturally occurring plant phenols in protecting against 7,12-dimethylbenz(a)anthracene-, benzo(a)pyrene-, 3-methylcholanthrene-, and N-methyl-N-nitrosourea-induced skin tumorigenesis in mice. Cancer Res 1988;48:2361-5.
37. Young MR, Li JJ, Rincon M, et al. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc Natl Acad Sci U S A 1999;96:9827-32.
38. Bowden GT. Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling. Nat Rev 2004;4:23-35.
39. He Z, Cho YY, Ma WY, Choi HS, Bode AM, Dong Z. Regulation of ultraviolet B-induced phosphorylation of histone H3 at serine 10 by Fyn kinase. J Biol Chem 2005;280:2446-54.
40. Wellbrock C, Weisser C, Geissinger E, Troppmair J, Schartl M. Activation of p59(Fyn) leads to melanocyte dedifferentiation by influencing MKP-1-regulated mitogen-activated protein kinase signaling. J Biol Chem 2002;277:6443-54.
41. Li W, Marshall C, Mei L, Gelfand J, Seykora JT. Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation. J Biol Chem 2007;282:1161-9.
42. He Z, Tang F, Ermakova S, et al. Fyn is a novel target of (-)-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation. Mol Carcinog 2008;47:172-83.
43. Zhang Y, Liu G, Dong Z. MSK1 and JNKs mediate phosphorylation of STAT3 in UVA-irradiated mouse epidermal JB6 cells. J Biol Chem 2001;276:42534-42.
44. Li W, Marshall C, Mei L, et al. Srcasm modulates EGF and Src-kinase signaling in keratinocytes. J Biol Chem 2005;280:6036-46.
45. Kinoshita T, Matsubara M, Ishiguro H, Okita K, Tada T. Structure of human Fyn kinase domain complexed with staurosporine. Biochem Biophys Res Commun 2006;346:840-4.